Cargando…

Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model

OBJECTIVE: Pituitary adenylate cyclase–activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthrit...

Descripción completa

Detalles Bibliográficos
Autores principales: Botz, Bálint, Bölcskei, Kata, Kereskai, László, Kovács, Miklós, Németh, Tamás, Szigeti, Krisztián, Horváth, Ildikó, Máthé, Domokos, Kovács, Noémi, Hashimoto, Hitoshi, Reglődi, Dóra, Szolcsányi, János, Pintér, Erika, Mócsai, Attila, Helyes, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320777/
https://www.ncbi.nlm.nih.gov/pubmed/25048575
http://dx.doi.org/10.1002/art.38772
_version_ 1782356182597369856
author Botz, Bálint
Bölcskei, Kata
Kereskai, László
Kovács, Miklós
Németh, Tamás
Szigeti, Krisztián
Horváth, Ildikó
Máthé, Domokos
Kovács, Noémi
Hashimoto, Hitoshi
Reglődi, Dóra
Szolcsányi, János
Pintér, Erika
Mócsai, Attila
Helyes, Zsuzsanna
author_facet Botz, Bálint
Bölcskei, Kata
Kereskai, László
Kovács, Miklós
Németh, Tamás
Szigeti, Krisztián
Horváth, Ildikó
Máthé, Domokos
Kovács, Noémi
Hashimoto, Hitoshi
Reglődi, Dóra
Szolcsányi, János
Pintér, Erika
Mócsai, Attila
Helyes, Zsuzsanna
author_sort Botz, Bálint
collection PubMed
description OBJECTIVE: Pituitary adenylate cyclase–activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthritis. METHODS: Arthritis was induced in PACAP(−/−) and wild-type (PACAP(+/+)) mice by K/BxN serum transfer. General features of the disease were investigated by semiquantitative scoring, plethysmometry, and histopathologic analysis. Mechano- and thermonociceptive thresholds and motor functions were also evaluated. Metabolic activity was assessed by positron emission tomography. Bone morphology was measured by in vivo micro–computed tomography, myeloperoxidase activity and superoxide production by bioluminescence imaging with luminol and lucigenin, respectively, and vascular permeability by fluorescent indocyanine green dye study. RESULTS: PACAP(+/+) mice developed notable joint swelling, reduced grasping ability, and mechanical (but not thermal) hyperalgesia after K/BxN serum transfer. In PACAP(−/−) mice clinical scores and edema were significantly reduced, and mechanical hyperalgesia and motor impairment were absent, throughout the 2-week period of observation. Metabolic activity and superoxide production increased in the tibiotarsal joints of wild-type mice but were significantly lower in PACAP(−/−) animals. Myeloperoxidase activity in the ankle joints of PACAP(−/−) mice was significantly reduced in the early phase of arthritis, but increased in the late phase. Synovial hyperplasia was also significantly increased, and progressive bone spur formation was observed in PACAP-deficient mice only. CONCLUSION: In PACAP-deficient mice with serum-transfer arthritis, joint swelling, vascular leakage, hyperalgesia, and early inflammatory cell accumulation are reduced; in the later phase of the disease, immune cell function and bone neoformation are increased. Elucidation of the underlying pathways of PACAP activity may open promising new avenues for development of therapy in inflammatory arthritis.
format Online
Article
Text
id pubmed-4320777
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43207772015-02-13 Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model Botz, Bálint Bölcskei, Kata Kereskai, László Kovács, Miklós Németh, Tamás Szigeti, Krisztián Horváth, Ildikó Máthé, Domokos Kovács, Noémi Hashimoto, Hitoshi Reglődi, Dóra Szolcsányi, János Pintér, Erika Mócsai, Attila Helyes, Zsuzsanna Arthritis Rheumatol Experimental Arthritis OBJECTIVE: Pituitary adenylate cyclase–activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthritis. METHODS: Arthritis was induced in PACAP(−/−) and wild-type (PACAP(+/+)) mice by K/BxN serum transfer. General features of the disease were investigated by semiquantitative scoring, plethysmometry, and histopathologic analysis. Mechano- and thermonociceptive thresholds and motor functions were also evaluated. Metabolic activity was assessed by positron emission tomography. Bone morphology was measured by in vivo micro–computed tomography, myeloperoxidase activity and superoxide production by bioluminescence imaging with luminol and lucigenin, respectively, and vascular permeability by fluorescent indocyanine green dye study. RESULTS: PACAP(+/+) mice developed notable joint swelling, reduced grasping ability, and mechanical (but not thermal) hyperalgesia after K/BxN serum transfer. In PACAP(−/−) mice clinical scores and edema were significantly reduced, and mechanical hyperalgesia and motor impairment were absent, throughout the 2-week period of observation. Metabolic activity and superoxide production increased in the tibiotarsal joints of wild-type mice but were significantly lower in PACAP(−/−) animals. Myeloperoxidase activity in the ankle joints of PACAP(−/−) mice was significantly reduced in the early phase of arthritis, but increased in the late phase. Synovial hyperplasia was also significantly increased, and progressive bone spur formation was observed in PACAP-deficient mice only. CONCLUSION: In PACAP-deficient mice with serum-transfer arthritis, joint swelling, vascular leakage, hyperalgesia, and early inflammatory cell accumulation are reduced; in the later phase of the disease, immune cell function and bone neoformation are increased. Elucidation of the underlying pathways of PACAP activity may open promising new avenues for development of therapy in inflammatory arthritis. BlackWell Publishing Ltd 2014-10 2014-09-26 /pmc/articles/PMC4320777/ /pubmed/25048575 http://dx.doi.org/10.1002/art.38772 Text en © 2014 The Authors. Arthritis & Rheumatology is published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Experimental Arthritis
Botz, Bálint
Bölcskei, Kata
Kereskai, László
Kovács, Miklós
Németh, Tamás
Szigeti, Krisztián
Horváth, Ildikó
Máthé, Domokos
Kovács, Noémi
Hashimoto, Hitoshi
Reglődi, Dóra
Szolcsányi, János
Pintér, Erika
Mócsai, Attila
Helyes, Zsuzsanna
Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
title Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
title_full Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
title_fullStr Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
title_full_unstemmed Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
title_short Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
title_sort differential regulatory role of pituitary adenylate cyclase–activating polypeptide in the serum-transfer arthritis model
topic Experimental Arthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320777/
https://www.ncbi.nlm.nih.gov/pubmed/25048575
http://dx.doi.org/10.1002/art.38772
work_keys_str_mv AT botzbalint differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT bolcskeikata differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT kereskailaszlo differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT kovacsmiklos differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT nemethtamas differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT szigetikrisztian differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT horvathildiko differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT mathedomokos differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT kovacsnoemi differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT hashimotohitoshi differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT reglodidora differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT szolcsanyijanos differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT pintererika differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT mocsaiattila differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel
AT helyeszsuzsanna differentialregulatoryroleofpituitaryadenylatecyclaseactivatingpolypeptideintheserumtransferarthritismodel